However, we believe that this study is necessary because this is the first study determining serum cytokines including Th1 (IFN-γ), Th2 (IL-6), Th17 (IL-17), Tregs (IL-35), and TNF-α in RA patients treated by tofacitinib. This evidence concerns the gene IFNG and rheumatoid arthritis.